Theodor Hansson is an accomplished business leader with over 25 years of experience in the pharmaceutical industry. Currently serving as the Business Unit Director for Cardiovascular Renal & Metabolism at AstraZeneca, Hansson heads a fast-growing unit in the Europe & Canada region. Previously, they held key positions at Boehringer Ingelheim, where they successfully built the Nordic diabetes portfolio and led numerous brand launches. Hansson holds a Bachelor of Science in Business Administration Economics from Göteborgs universitet and an Executive MBA specializing in Leadership, Strategy, and Finance.
This person is not in the org chart
This person is not in any teams
This person is not in any offices